Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
SYNDAX PHARMACEUTICALS, INC. <SNDX.O>: UBS CUTS TARGET PRICE TO $33 FROM $37

SYNDAX PHARMACEUTICALS, INC. <SNDX.O>: UBS CUTS TARGET PRICE TO $33 FROM $37

ReutersReuters2026/08/21 12:13
By:Reuters
SYNDAX PHARMACEUTICALS, INC.
: UBS CUTS TARGET PRICE TO $33 FROM $37
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!